By Industry Standard Research
ISR recently surveyed decision makers across all phases of clinical development to gain insight on sponsor/CRO dynamics. More than half of respondents agreed (to some level) that their organization would change its mix of CROs. Superior HEOR (health economics outcomes research) or real-world expertise was what most likely would prompt a change.
“Please indicate your level of agreement with each of the following statements:” (n=508)
“Using the scenarios listed below, please indicate how likely your organization would be to change the mix of CROs based on the scenario. We define ‘change the mix of CROs’ not as whether your outsourcing would increase or decrease, but rather how your outsourced work might change across or between CROs.” (n=508)